Home › Funds › Red Spruce Capital, LLC › ABT

Red Spruce Capital, LLC position in ABT

ABBOTT LABORATORIES · Health Care

Red Spruce Capital, LLC reported holding 35,282 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$3.5M, representing 1.23% of its reported portfolio and ranking #27 among its reported holdings. Red Spruce Capital, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)35.28K sh
Reported value held$3.49M
Portfolio Weight1.23%
First reportedQ3 2023
Last changeReduce
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How Red Spruce Capital, LLC's ABT position evolved

Red Spruce Capital, LLC first disclosed a stake in ABT in Q3 2023 at 25,204 shares (US$2.4M). The position peaked in Q1 2025 at 33,804 shares, worth US$4.5M. Across 13 filings, Red Spruce Capital, LLC increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 35,282 shares valued at US$3.5M — a reduction of -928 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 25.20K $2.44M New
Q4 2023 29.02K $3.19M Add
Q1 2024 31.40K $3.57M Add
Q2 2024 32.72K $3.40M Add
Q3 2024 33.29K $3.80M Add
Q4 2024 34.63K $3.92M Add
Q1 2025 33.80K $4.48M Reduce
Q2 2025 28.40K $3.86M Reduce
Q3 2025 28.09K $3.76M Reduce
Q4 2025 27.73K $3.47M Reduce
Q1 2026 29.13K $2.99M Add
Q2 2026 36.21K $3.29M Add
Q3 2026 35.28K $3.49M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Red Spruce Capital, LLC held ABT?

Red Spruce Capital, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Red Spruce Capital, LLC's current position in ABT?

As of Q3 2026, Red Spruce Capital, LLC holds 35.28K shares of ABT (ABBOTT LABORATORIES), valued at $3.49M, representing 1.23% of its reported portfolio and ranking #27.

Has Red Spruce Capital, LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), Red Spruce Capital, LLC reduced its position in ABT. The position peaked in Q1 2025 at 33.80K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.